List of Xenon Pharmaceuticals patents

Patents where

Current Assignee

Name

Xenon Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8466188 Use of spiro-oxindole compounds as therapeutic agents	Patent 8466188 was granted and assigned to Xenon Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	8466188	June 18, 2013
‌ US Patent 7919484 Combination therapy	Patent 7919484 was granted and assigned to Xenon Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7919484	April 5, 2011
‌ US Patent 7605161 Pyridyl derivatives and their use as therapeutic agents	Patent 7605161 was granted and assigned to Xenon Pharmaceuticals on October, 2009 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7605161	October 20, 2009
‌ US Patent 11135214 Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener	Patent 11135214 was granted and assigned to Xenon Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	11135214	October 5, 2021
‌ US Patent 8080651 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof	Patent 8080651 was granted and assigned to Xenon Pharmaceuticals on December, 2011 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	8080651	December 20, 2011
‌ US Patent 11325902 Benzenesulfonamide compounds and their use as therapeutic agents	Patent 11325902 was granted and assigned to Xenon Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	11325902	May 10, 2022
‌ US Patent 7767677 Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors	Patent 7767677 was granted and assigned to Xenon Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7767677	August 3, 2010
‌ US Patent 9630929 Benzenesulfonamide compounds and their use as therapeutic agents	Patent 9630929 was granted and assigned to Xenon Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	9630929	April 25, 2017
‌ US Patent 7294480 High throughput screening assays using fatty acid synthetic enzymes	Patent 7294480 was granted and assigned to Xenon Pharmaceuticals on November, 2007 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7294480	November 13, 2007
‌ US Patent 7456180 Piperazine derivatives and their use as therapeutic agents	Patent 7456180 was granted and assigned to Xenon Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7456180	November 25, 2008
‌ US Patent 7547698 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)	Patent 7547698 was granted and assigned to Xenon Pharmaceuticals on June, 2009 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7547698	June 16, 2009
‌ US Patent 11299490 Benzenesulfonamide compounds and their use as therapeutic agents	Patent 11299490 was granted and assigned to Xenon Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	11299490	April 12, 2022
‌ US Patent 8742109 Synthetic methods for spiro-oxindole compounds	Patent 8742109 was granted and assigned to Xenon Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	8742109	June 3, 2014
‌ US Patent 7514436 Pyridazine derivatives and their use as therapeutic agents	Patent 7514436 was granted and assigned to Xenon Pharmaceuticals on April, 2009 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7514436	April 7, 2009
‌ US Patent 9458178 Spiro-oxindole compounds and their use as therapeutic agents	Patent 9458178 was granted and assigned to Xenon Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	9458178	October 4, 2016
‌ US Patent 7754711 Pyridazine derivatives and their use as therapeutic agents	Patent 7754711 was granted and assigned to Xenon Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7754711	July 13, 2010
‌ US Patent 9481677 Biaryl ether sulfonamides and their use as therapeutic agents	Patent 9481677 was granted and assigned to Xenon Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	9481677	November 1, 2016
‌ US Patent 7390813 Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents	Patent 7390813 was granted and assigned to Xenon Pharmaceuticals on June, 2008 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7390813	June 24, 2008
‌ US Patent 10246453 Benzenesulfonamide compounds and their use as therapeutic agents	Patent 10246453 was granted and assigned to Xenon Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	10246453	April 2, 2019
‌ US Patent 11174268 Benzenesulfonamide compouds and their use as therapeutic agents	Patent 11174268 was granted and assigned to Xenon Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	11174268	November 16, 2021
‌ US Patent 8415370 Spiro-oxindole compounds and their uses as therapeutic agents	Patent 8415370 was granted and assigned to Xenon Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	8415370	April 9, 2013
‌ US Patent 8263606 Spiro-oxindole compounds and their use as therapeutic agents	Patent 8263606 was granted and assigned to Xenon Pharmaceuticals on September, 2012 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	8263606	September 11, 2012
‌ US Patent 11091441 Solid state crystalline forms of a selective potassium channel modulator	Patent 11091441 was granted and assigned to Xenon Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.	Xenon Pharmaceuticals	Xenon Pharmaceuticals	United States Patent and Trademark Office	11091441	August 17, 2021
‌ US Patent 8153636 Pyridyl derivatives and their use as therapeutic agents	Patent 8153636 was granted and assigned to Xenon Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	8153636	April 10, 2012
‌ US Patent 7700641 Spiro-oxindole compounds and their uses as therapeutic agents	Patent 7700641 was granted and assigned to Xenon Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		Xenon Pharmaceuticals	United States Patent and Trademark Office	7700641	April 20, 2010

Results per page:

71 results

0 selected

71 results

0 selected